ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report

Multiple cancers are a common occurrence, and the choice of treatment can be a challenging decision. The current case report describes a 71-year-old woman with overlapping anaplastic lymphoma kinase (ALK)-rearranged lung adenocarcinoma and HER2-mutant breast cancer, who achieved improvement with con...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayasu, Hirokazu, Kata, Yuki, Otsu, Yukiko, Inoue, Satoshi, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129291/
https://www.ncbi.nlm.nih.gov/pubmed/37113357
http://dx.doi.org/10.7759/cureus.36711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129291/
https://www.ncbi.nlm.nih.gov/pubmed/37113357
http://dx.doi.org/10.7759/cureus.36711

Ejemplares similares